vs

Side-by-side financial comparison of Genie Energy Ltd. (GNE) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

Genie Energy Ltd. is the larger business by last-quarter revenue ($138.3M vs $76.4M, roughly 1.8× PROCEPT BioRobotics Corp). Genie Energy Ltd. runs the higher net margin — 4.9% vs -39.1%, a 43.9% gap on every dollar of revenue. On growth, Genie Energy Ltd. posted the faster year-over-year revenue change (23.6% vs 11.9%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (31.0% CAGR vs 14.8%).

Genie Energy Ltd. is an American energy company headquartered in Newark, New Jersey. It is a holding company comprising Genie Retail Energy, Genie Retail Energy International, Genie Energy Services, and Genie Energy Oil and Gas. Michael Stein is the Chief Executive Officer, Genie Energy Ltd.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

GNE vs PRCT — Head-to-Head

Bigger by revenue
GNE
GNE
1.8× larger
GNE
$138.3M
$76.4M
PRCT
Growing faster (revenue YoY)
GNE
GNE
+11.7% gap
GNE
23.6%
11.9%
PRCT
Higher net margin
GNE
GNE
43.9% more per $
GNE
4.9%
-39.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
31.0%
14.8%
GNE

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
GNE
GNE
PRCT
PRCT
Revenue
$138.3M
$76.4M
Net Profit
$6.7M
$-29.8M
Gross Margin
21.7%
60.6%
Operating Margin
5.0%
-40.6%
Net Margin
4.9%
-39.1%
Revenue YoY
23.6%
11.9%
Net Profit YoY
-33.9%
-58.3%
EPS (diluted)
$0.26
$-0.54

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GNE
GNE
PRCT
PRCT
Q4 25
$76.4M
Q3 25
$138.3M
$83.3M
Q2 25
$105.3M
$79.2M
Q1 25
$136.8M
$69.2M
Q4 24
$102.9M
$68.2M
Q3 24
$111.9M
$58.4M
Q2 24
$90.7M
$53.4M
Q1 24
$119.7M
$44.5M
Net Profit
GNE
GNE
PRCT
PRCT
Q4 25
$-29.8M
Q3 25
$6.7M
$-21.4M
Q2 25
$2.8M
$-19.6M
Q1 25
$10.3M
$-24.7M
Q4 24
$-15.3M
$-18.9M
Q3 24
$10.2M
$-21.0M
Q2 24
$9.6M
$-25.6M
Q1 24
$8.1M
$-26.0M
Gross Margin
GNE
GNE
PRCT
PRCT
Q4 25
60.6%
Q3 25
21.7%
64.8%
Q2 25
22.3%
65.4%
Q1 25
27.3%
63.9%
Q4 24
32.5%
64.0%
Q3 24
33.9%
63.2%
Q2 24
36.8%
59.0%
Q1 24
28.2%
56.2%
Operating Margin
GNE
GNE
PRCT
PRCT
Q4 25
-40.6%
Q3 25
5.0%
-27.8%
Q2 25
1.9%
-28.0%
Q1 25
9.4%
-39.7%
Q4 24
-20.2%
-28.9%
Q3 24
10.4%
-38.4%
Q2 24
11.6%
-50.3%
Q1 24
8.2%
-62.1%
Net Margin
GNE
GNE
PRCT
PRCT
Q4 25
-39.1%
Q3 25
4.9%
-25.7%
Q2 25
2.7%
-24.7%
Q1 25
7.5%
-35.8%
Q4 24
-14.9%
-27.6%
Q3 24
9.1%
-35.9%
Q2 24
10.6%
-48.0%
Q1 24
6.8%
-58.3%
EPS (diluted)
GNE
GNE
PRCT
PRCT
Q4 25
$-0.54
Q3 25
$0.26
$-0.38
Q2 25
$0.11
$-0.35
Q1 25
$0.40
$-0.45
Q4 24
$-0.58
$-0.34
Q3 24
$0.38
$-0.40
Q2 24
$0.36
$-0.50
Q1 24
$0.30
$-0.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GNE
GNE
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$109.8M
$286.5M
Total DebtLower is stronger
$51.6M
Stockholders' EquityBook value
$198.8M
$365.9M
Total Assets
$394.1M
$508.1M
Debt / EquityLower = less leverage
0.14×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GNE
GNE
PRCT
PRCT
Q4 25
$286.5M
Q3 25
$109.8M
$294.3M
Q2 25
$106.0M
$302.7M
Q1 25
$118.3M
$316.2M
Q4 24
$110.1M
$333.7M
Q3 24
$141.8M
$196.8M
Q2 24
$126.8M
$214.1M
Q1 24
$106.9M
$225.6M
Total Debt
GNE
GNE
PRCT
PRCT
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Q1 24
$51.4M
Stockholders' Equity
GNE
GNE
PRCT
PRCT
Q4 25
$365.9M
Q3 25
$198.8M
$380.3M
Q2 25
$197.0M
$385.8M
Q1 25
$198.0M
$389.2M
Q4 24
$190.5M
$402.2M
Q3 24
$211.1M
$241.2M
Q2 24
$202.1M
$251.8M
Q1 24
$192.9M
$264.0M
Total Assets
GNE
GNE
PRCT
PRCT
Q4 25
$508.1M
Q3 25
$394.1M
$511.5M
Q2 25
$383.1M
$513.1M
Q1 25
$384.4M
$519.4M
Q4 24
$371.3M
$534.0M
Q3 24
$341.7M
$374.1M
Q2 24
$322.8M
$374.4M
Q1 24
$328.3M
$382.9M
Debt / Equity
GNE
GNE
PRCT
PRCT
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×
Q1 24
0.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GNE
GNE
PRCT
PRCT
Operating Cash FlowLast quarter
$13.9M
$-10.3M
Free Cash FlowOCF − Capex
$-12.2M
FCF MarginFCF / Revenue
-15.9%
Capex IntensityCapex / Revenue
2.4%
Cash ConversionOCF / Net Profit
2.07×
TTM Free Cash FlowTrailing 4 quarters
$-58.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GNE
GNE
PRCT
PRCT
Q4 25
$-10.3M
Q3 25
$13.9M
$-6.6M
Q2 25
$1.1M
$-15.0M
Q1 25
$15.3M
$-17.0M
Q4 24
$13.0M
$-32.4M
Q3 24
$24.4M
$-18.8M
Q2 24
$20.4M
$-15.7M
Q1 24
$12.9M
$-32.3M
Free Cash Flow
GNE
GNE
PRCT
PRCT
Q4 25
$-12.2M
Q3 25
$-9.5M
Q2 25
$-17.8M
Q1 25
$13.6M
$-18.8M
Q4 24
$-33.6M
Q3 24
$21.9M
$-19.0M
Q2 24
$20.1M
$-16.8M
Q1 24
$11.7M
$-34.2M
FCF Margin
GNE
GNE
PRCT
PRCT
Q4 25
-15.9%
Q3 25
-11.4%
Q2 25
-22.5%
Q1 25
9.9%
-27.2%
Q4 24
-49.2%
Q3 24
19.6%
-32.6%
Q2 24
22.1%
-31.4%
Q1 24
9.8%
-76.9%
Capex Intensity
GNE
GNE
PRCT
PRCT
Q4 25
2.4%
Q3 25
3.4%
Q2 25
3.5%
Q1 25
1.3%
2.7%
Q4 24
1.7%
Q3 24
2.2%
0.4%
Q2 24
0.4%
2.0%
Q1 24
1.0%
4.4%
Cash Conversion
GNE
GNE
PRCT
PRCT
Q4 25
Q3 25
2.07×
Q2 25
0.40×
Q1 25
1.49×
Q4 24
Q3 24
2.39×
Q2 24
2.12×
Q1 24
1.59×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GNE
GNE

Sales Channel Directly To Consumer$108.8M79%
Sales Channel Through Intermediary$23.5M17%
Genie Renewables GREW$6.0M4%

PRCT
PRCT

Hand Pieces And Other Consumables$34.1M45%
System Sales And Rentals$27.5M36%
Other$9.8M13%
Service Revenue$5.0M7%

Related Comparisons